S&P 500   3,387.27 (+0.50%)
DOW   29,349.38 (+0.40%)
QQQ   236.96 (+0.95%)
AAPL   323.23 (+1.33%)
FB   217.67 (-0.06%)
MSFT   187.29 (+0.03%)
GOOGL   1,525.81 (+0.42%)
AMZN   2,173.68 (+0.84%)
CGC   21.84 (-0.46%)
BABA   222.36 (+0.83%)
MU   59.99 (+3.86%)
GE   12.61 (-1.10%)
TSLA   910.08 (+6.02%)
AMD   58.84 (+3.43%)
T   38.44 (+0.47%)
ACB   1.71 (+4.28%)
PRI   136.15 (+0.39%)
BAC   34.77 (+1.43%)
DIS   141.36 (+1.60%)
GILD   67.40 (+0.58%)
S&P 500   3,387.27 (+0.50%)
DOW   29,349.38 (+0.40%)
QQQ   236.96 (+0.95%)
AAPL   323.23 (+1.33%)
FB   217.67 (-0.06%)
MSFT   187.29 (+0.03%)
GOOGL   1,525.81 (+0.42%)
AMZN   2,173.68 (+0.84%)
CGC   21.84 (-0.46%)
BABA   222.36 (+0.83%)
MU   59.99 (+3.86%)
GE   12.61 (-1.10%)
TSLA   910.08 (+6.02%)
AMD   58.84 (+3.43%)
T   38.44 (+0.47%)
ACB   1.71 (+4.28%)
PRI   136.15 (+0.39%)
BAC   34.77 (+1.43%)
DIS   141.36 (+1.60%)
GILD   67.40 (+0.58%)
S&P 500   3,387.27 (+0.50%)
DOW   29,349.38 (+0.40%)
QQQ   236.96 (+0.95%)
AAPL   323.23 (+1.33%)
FB   217.67 (-0.06%)
MSFT   187.29 (+0.03%)
GOOGL   1,525.81 (+0.42%)
AMZN   2,173.68 (+0.84%)
CGC   21.84 (-0.46%)
BABA   222.36 (+0.83%)
MU   59.99 (+3.86%)
GE   12.61 (-1.10%)
TSLA   910.08 (+6.02%)
AMD   58.84 (+3.43%)
T   38.44 (+0.47%)
ACB   1.71 (+4.28%)
PRI   136.15 (+0.39%)
BAC   34.77 (+1.43%)
DIS   141.36 (+1.60%)
GILD   67.40 (+0.58%)
S&P 500   3,387.27 (+0.50%)
DOW   29,349.38 (+0.40%)
QQQ   236.96 (+0.95%)
AAPL   323.23 (+1.33%)
FB   217.67 (-0.06%)
MSFT   187.29 (+0.03%)
GOOGL   1,525.81 (+0.42%)
AMZN   2,173.68 (+0.84%)
CGC   21.84 (-0.46%)
BABA   222.36 (+0.83%)
MU   59.99 (+3.86%)
GE   12.61 (-1.10%)
TSLA   910.08 (+6.02%)
AMD   58.84 (+3.43%)
T   38.44 (+0.47%)
ACB   1.71 (+4.28%)
PRI   136.15 (+0.39%)
BAC   34.77 (+1.43%)
DIS   141.36 (+1.60%)
GILD   67.40 (+0.58%)
Log in

NASDAQ:QTNT - Quotient Stock Price, Forecast & News

$7.24
0.00 (0.00 %)
(As of 02/19/2020 03:50 PM ET)
Today's Range
$7.05
Now: $7.24
$7.37
50-Day Range
$6.93
MA: $8.12
$9.51
52-Week Range
$6.79
Now: $7.24
$11.30
Volume215,066 shs
Average Volume442,175 shs
Market Capitalization$581.44 million
P/E RatioN/A
Dividend YieldN/A
Beta1.03
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood-group antigens; reagent red blood cells, which enable the identification of blood-group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. Read More…

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:QTNT
CUSIPN/A
Phone011-41-22-716-9800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$29.13 million
Book Value$0.22 per share

Profitability

Net Income$-105,390,000.00
Net Margins-324.59%

Miscellaneous

EmployeesN/A
Market Cap$581.44 million
Next Earnings Date5/26/2020 (Estimated)
OptionableOptionable

Receive QTNT News and Ratings via Email

Sign-up to receive the latest news and ratings for QTNT and its competitors with MarketBeat's FREE daily newsletter.


Quotient (NASDAQ:QTNT) Frequently Asked Questions

What is Quotient's stock symbol?

Quotient trades on the NASDAQ under the ticker symbol "QTNT."

How were Quotient's earnings last quarter?

Quotient Ltd (NASDAQ:QTNT) released its earnings results on Thursday, January, 30th. The company reported ($0.37) EPS for the quarter, beating analysts' consensus estimates of ($0.41) by $0.04. The business had revenue of $7.94 million for the quarter, compared to the consensus estimate of $7.10 million. View Quotient's Earnings History.

When is Quotient's next earnings date?

Quotient is scheduled to release their next quarterly earnings announcement on Tuesday, May 26th 2020. View Earnings Estimates for Quotient.

What price target have analysts set for QTNT?

1 equities research analysts have issued 12-month price objectives for Quotient's stock. Their forecasts range from $13.50 to $13.50. On average, they expect Quotient's stock price to reach $13.50 in the next twelve months. This suggests a possible upside of 85.7% from the stock's current price. View Analyst Price Targets for Quotient.

What is the consensus analysts' recommendation for Quotient?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quotient in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Quotient.

Has Quotient been receiving favorable news coverage?

News headlines about QTNT stock have trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Quotient earned a news sentiment score of 0.6 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Quotient.

Who are some of Quotient's key competitors?

What other stocks do shareholders of Quotient own?

Who are Quotient's key executives?

Quotient's management team includes the folowing people:
  • Mr. Franz Walt, CEO & Director (Age 60)
  • Mr. Jeremy Stackawitz, Pres (Age 44)
  • Mr. Edward Farrell, Pres (Age 49)
  • Mr. Christopher J. Lindop, Chief Financial Officer (Age 61)
  • Mr. John Allan, Corp. Sr. VP & CTO

Who are Quotient's major shareholders?

Quotient's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Perceptive Advisors LLC (16.55%), Farallon Capital Management LLC (3.11%), Credit Suisse AG (3.04%), FMR LLC (2.51%), Broadfin Capital LLC (2.48%) and Artisan Partners Limited Partnership (1.57%). Company insiders that own Quotient stock include Edward Farrell, Frederick Hallsworth, Jeremy Stackawitz, Life Sciences Maste Perceptive, Perceptive Advisors Llc, Prondzynski Heino Von and Roland Boyd. View Institutional Ownership Trends for Quotient.

Which institutional investors are selling Quotient stock?

QTNT stock was sold by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., FMR LLC, Marshall Wace North America L.P., Goldman Sachs Group Inc., Cubist Systematic Strategies LLC and FNY Investment Advisers LLC. Company insiders that have sold Quotient company stock in the last year include Edward Farrell, Jeremy Stackawitz and Roland Boyd. View Insider Buying and Selling for Quotient.

Which institutional investors are buying Quotient stock?

QTNT stock was acquired by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Broadfin Capital LLC, Farallon Capital Management LLC, Credit Suisse AG, Artisan Partners Limited Partnership, Castleark Management LLC, Sei Investments Co. and Marshall Wace LLP. Company insiders that have bought Quotient stock in the last two years include Frederick Hallsworth, Life Sciences Maste Perceptive, Perceptive Advisors Llc and Prondzynski Heino Von. View Insider Buying and Selling for Quotient.

How do I buy shares of Quotient?

Shares of QTNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Quotient's stock price today?

One share of QTNT stock can currently be purchased for approximately $7.27.

How big of a company is Quotient?

Quotient has a market capitalization of $583.85 million and generates $29.13 million in revenue each year. The company earns $-105,390,000.00 in net income (profit) each year or ($1.92) on an earnings per share basis. View Additional Information About Quotient.

What is Quotient's official website?

The official website for Quotient is http://www.quotientbd.com/.

How can I contact Quotient?

Quotient's mailing address is B1 Business Park Terre Bonne Route de Crassier 13, Eysins Y9, 1262. The company can be reached via phone at 011-41-22-716-9800.


MarketBeat Community Rating for Quotient (NASDAQ QTNT)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  280 (Vote Outperform)
Underperform Votes:  287 (Vote Underperform)
Total Votes:  567
MarketBeat's community ratings are surveys of what our community members think about Quotient and other stocks. Vote "Outperform" if you believe QTNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe QTNT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Featured Article: Range Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel